Mounting evidence of PAP therapy’s benefits in largest series to date
Paves way for phase 3 testing of novel treatment approach
A trial status update and overview of investigational aspects
$8.75M award will help probe links with immune-related neuroinflammation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
$10.6M award to help compare escalation with early highly effective treatment
Two weeks of therapy yields sustained benefits
Preliminary findings may augur risk of long-term brain decline
Study demonstrates benefits in health status, depression and more
Effects specific to affective pain sphere argue for shift in surgical targeting
Possible surrogate biomarker for AD subtype, retrospective study suggests
Advertisement
Advertisement